Skip to main content

COVID-19 Topic Center

Commentary

Commentary
Ann Latner, JD, reviews a recent bill passed by the Ohio House of Representatives that increases the number of times a pharmacist can dispense a life-saving medication without a prescription in a year.
Commentary
This week, Dr Jennings take a brief (and rare) journey into the basic science realm to explore the potential of combination antiviral use for the treatment of COVID-19. 
Commentary
Jill Paslier, PharmD, CSP, international safe medication management fellow, Institute for Safe Medication Practices, explains why pharmacy staff should approach all patient reporting errors or potential medication errors with transparency and empathy to maintain a positive relationship with the…
Commentary
Soumya Vishwanath, PharmD, University of Massachusetts Medical School, discusses digital therapeutics, which she says is the next wave of patient care, and highlights why it’s essential to assess how these products may play a role in clinical therapy and evaluate their impact on key stakeholders.
Commentary
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
Commentary
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
Commentary
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
Commentary
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients are kept safe.
Commentary
“Health care providers can be instrumental in recognizing and helping patients suffering with mental health issues by keeping the lines of communication open and providing patients with encouragement and support,” says Yvette C Terrie, BS Pharm, RPh, consultant pharmacist.
Commentary
When combining the high prevalence of hypertension with new aggressive treatment targets, a lot of patients may face the risk of having to take numerous drugs. In this week’s issue of Talking Therapeutics, Dr Jennings looks at a few recent and interesting articles surrounding this timely topic.
Back to Top